We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONEW icon
3076
OneWater Marine
ONEW
$198M
$111K ﹤0.01%
5,408
+4,462
+472% +$113K
RDVT icon
3077
Red Violet
RDVT
$1.12B
$111K ﹤0.01%
6,061
-5,369
-47% -$96.7K
UNTY icon
3078
Unity Bancorp
UNTY
$615M
$111K ﹤0.01%
9,633
+7,933
+467% +$104K
AGTC
3079
DELISTED
Applied Genetic Technologies Corporation
AGTC
$111K ﹤0.01%
22,794
+21,303
+1,429% +$116K
BPRN icon
3080
Princeton Bancorp
BPRN
$295M
$110K ﹤0.01%
6,054
+4,881
+416% +$92.2K
ETON icon
3081
Eton Pharmaceutcials
ETON
$1.6B
$110K ﹤0.01%
13,936
-1,950
-12% -$13.3K
FNB icon
3082
FNB Corp
FNB
$6.91B
$110K ﹤0.01%
16,130
-127,696
-89% -$937K
GBDC icon
3083
Golub Capital BDC
GBDC
$3.45B
$110K ﹤0.01%
8,271
+5,169
+167% +$64.6K
HBIO icon
3084
Harvard Bioscience
HBIO
$30.5M
$110K ﹤0.01%
3,672
+2,931
+396% +$98.6K
HDV
3085
iShares Core High Dividend ETF
HDV
$15.2B
$110K ﹤0.01%
6,875
-89,900
-93% -$1.5M
HRMY icon
3086
Harmony Biosciences
HRMY
$2.23B
$110K ﹤0.01%
+3,240
New +$118K
IWL icon
3087
iShares Russell Top 200 ETF
IWL
$2.28B
$110K ﹤0.01%
1,355
-43,756
-97% -$3.5M
PBFS icon
3088
Pioneer Bancorp
PBFS
$420M
$110K ﹤0.01%
12,360
+9,423
+321% +$81.8K
VWO icon
3089
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$110K ﹤0.01%
2,543
-17,403
-87% -$757K
PLAN
3090
DELISTED
Anaplan, Inc.
PLAN
$110K ﹤0.01%
1,755
-10,141
-85% -$523K
ATXS
3091
DELISTED
Astria Therapeutics
ATXS
$109K ﹤0.01%
2,927
+390
+15% +$15.5K
QGEN icon
3092
Qiagen
QGEN
$8.87B
$109K ﹤0.01%
1,961
-378
-16% -$19.6K
XLP icon
3093
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$109K ﹤0.01%
1,708
-47,513
-97% -$3M
RETA
3094
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$109K ﹤0.01%
1,121
-2,815
-72% -$352K
BBCP icon
3095
Concrete Pumping Holdings
BBCP
$479M
$108K ﹤0.01%
30,216
+24,494
+428% +$90.2K
PINE
3096
Alpine Income Property Trust
PINE
$348M
$108K ﹤0.01%
6,961
+6,525
+1,497% +$96.9K
PUMP icon
3097
ProPetro Holding
PUMP
$1.48B
$108K ﹤0.01%
26,585
+20,751
+356% +$113K
RHP icon
3098
Ryman Hospitality Properties
RHP
$7.91B
$108K ﹤0.01%
2,930
-1,508
-34% -$53.4K
WEYS icon
3099
Weyco Group
WEYS
$429M
$108K ﹤0.01%
6,672
+5,120
+330% +$93.5K
LOGC
3100
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$108K ﹤0.01%
11,913
+9,930
+501% +$75.3K
122 123
124
125 126

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.